Cancer patients, caregivers benefit with integrated clinic-to-pharmacy care through Prime Therapeutics IntegratedRx - Oncology.
ENPNewswire-October 19, 2021--Cancer patients, caregivers benefit with integrated clinic-to-pharmacy care through Prime Therapeutics IntegratedRx - Oncology
(C)2021 ENPublishing - http://www.enpublishing.co.uk
Release date- 18102021 - EAGAN, Minn. - Prime Therapeutics, a leading pharmacy benefit manager (PBM) serving more than 33 million members, introduced IntegratedRx - Oncology. This new clinically integrated program streamlines the treatment pathway for members who are fighting cancer so they can now receive their oral oncolytic and companion medications in the clinical setting directly from their oncologist's clinic or affiliated hospital pharmacy. This promotes lower drug costs, quicker time-to-medication, better adherence and an improved patient and provider experience for Blue Plans and their members.
The IntegratedRx - Oncology program represents Prime's channel independent approach of identifying solutions that drive the best financial and quality outcomes for Blue Plans and members. It makes Prime the only large PBM that doesn't prioritize a central fill specialty pharmacy as the primary model to receive their oral oncolytic medications.
The nationwide rollout of IntegratedRx - Oncology builds on a successful pilot program with McKesson Health Mart Atlas, the largest pharmacy services administrative organization (PSAO) in the U.S., conducted in Florida, Minnesota and the Pacific Northwest earlier this year. The integrated care pilot indicated benefits to providers as well as patients, including:
Shorter fill times allowing patients to begin treatment up to two days faster.
Significantly better medication adherence.
Reduced drug costs.
'We were delighted to work with Prime to innovate and develop this new program that employs a best-in-care integrated dispensing model for cancer medications,' said Mark Alwardt, vice president of Medically Integrated Dispensing at McKesson. 'At McKesson, we have a patient-first mentality and saw the opportunity to help deliver superior member outcomes through improved therapy management, a collaborative care model and expanded drug access.'
'By connecting the care team to the practice pharmacy, IntegratedRx Oncology removes roadblocks that can complicate the cancer care journey,' said Joseph Leach, M.D., chief medical officer for Prime and a practicing oncologist. 'This type of channel-agnostic approach is a hallmark of Prime's focus on improving the member and provider experience. An integrated...
To continue reading
Request your trial